"MIRAGRON ER 50: Effective Relief for Overactive Bladder Symptoms"

May 22, 2024

MIRAGRON ER 50 

Mirabegron (50mg)

Introduction to MIRAGRON ER 50

Mirabegron (50mg), marketed as MIRAGRON ER 50, is a medication primarily used to treat overactive bladder (OAB) symptoms such as urinary urgency, frequency, and incontinence. As an extended-release formulation, it provides consistent symptom control throughout the day, enhancing the quality of life for individuals with OAB.

Understanding Overactive Bladder (OAB)

What is Overactive Bladder?

  • Symptoms: OAB is characterized by a sudden and uncontrollable urge to urinate, frequent urination, and involuntary leakage (incontinence).
  • Prevalence: OAB affects millions of people worldwide, impacting daily activities and overall quality of life.

Causes of OAB

  • Bladder Muscle Dysfunction: Overactivity of the bladder muscle, known as the detrusor muscle, can cause OAB.
  • Neurological Conditions: Conditions like Parkinson's disease, multiple sclerosis, and stroke can contribute to OAB.
  • Lifestyle Factors: Excessive fluid intake, caffeine, and certain medications can exacerbate symptoms.

How MIRAGRON ER 50 Works

Mechanism of Action

  • Beta-3 Adrenergic Agonist: Mirabegron works by activating beta-3 adrenergic receptors in the bladder, leading to relaxation of the detrusor muscle.
  • Increased Bladder Capacity: This relaxation increases the bladder's ability to store urine, reducing the frequency and urgency of urination.

Benefits of MIRAGRON ER 50

  • Effective Symptom Relief: Provides significant reduction in OAB symptoms, improving daily life activities.
  • Convenient Dosing: As an extended-release tablet, it offers once-daily dosing for continuous symptom control.

Usage and Dosage

Recommended Dosage

  • Standard Dose: The typical dose for adults is 50mg once daily.
  • Administration: Take MIRAGRON ER 50 with or without food, swallowing the tablet whole without crushing or chewing.

Important Precautions

Side Effects of MIRAGRON ER 50

Common Side Effects

  • Increased Blood Pressure: Regular monitoring is necessary, particularly in patients with hypertension.
  • Headache: A relatively common side effect that may occur.
  • Urinary Tract Infection: Some patients may experience UTIs as a side effect.

Serious Side Effects

  • Heart Palpitations: Rare but can occur, requiring medical attention.
  • Severe Allergic Reactions: Symptoms like rash, itching, or swelling need immediate medical help.

Conclusion

Mirabegron (50mg) in the form of MIRAGRON ER 50 is a highly effective treatment for managing the symptoms of overactive bladder. By increasing bladder capacity and reducing urinary urgency and frequency, it significantly improves the quality of life for individuals with OAB. Consult with your healthcare provider to see if MIRAGRON ER 50 is the right option for you.Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 

   BUY NOW

SHARE WITH